How ADHD Affects Clinical Practice

Godfrey-Harris and Shaw (2023) define Attention Deficit/Hyperactivity Disorder (ADHD) as “a form of neurodivergence, characterized by lifelong differences in attention, impulsivity, and hyperactivity.” While there are considerations for each ADHD subtype, this article will only focus on general presentations as many co-morbidities may occur between the subtypes.

Read More

Viloxazine ER for ADHD Reduces Weight Among Adults With Overweight, Obesity

Relative to placebo, Viloxazine extended-release (viloxazine ER) treatment for attention-deficit hyperactivity disorder (ADHD) is associated with significant weight loss – particularly among adults with overweight and/or obesity at baseline. These study results were presented at Psych Congress 2024, held from October 29 to November 2, 2024 in Boston, Massachusetts.

Read More

Are Food Dyes Bad For Your Health?

In September, California became the first state in the nation to ban six artificial food dyes from meals served in public schools. The move followed a 2021 report from the state’s Office of Environmental Health Hazard Assessment (OEHHA) that concluded the body of evidence supported a relationship between food dye exposure and adverse behavioral outcomes…

Read More

ADHD: Overlooked Cause of Persistent Anxiety and Depression in Adults

Key Takeaways: ADHD in adults is underdiagnosed, often masked by comorbid conditions, leading to significant psychosocial impairments. Accurate diagnosis requires comprehensive history-taking, standardized tools, and functional assessments to differentiate from other psychiatric disorders. ADHD prevalence in adults is 2.5%, with high comorbidity rates with bipolar disorder, major depressive disorder, and substance use disorder. Early identification…

Read More